Back to search

Virginia Commonwealth University

The Role of Interleukin-18 in Myocardial Ischemia/Reperfusion

Abstract

dc:description.abstract

Acute Myocardial Infarction (AMI) is one of the leading causes of morbidity for cardiovascular diseases (CVDs) in the western world. While mortality rates for AMI has reduced in the last 20 years due to advancements in clinical interventions, patients who have an AMI are significantly more likely to develop heart failure (HF) in the following years. Reperfusion of the ischemic tissue is a necessary procedure to restore blood delivery to cardiomyocytes, minimize myocardial dysfunction, and reduce infarct size. Still, the step of reperfusion itself induces myocardial damage in a phenomenon known as reperfusion injury. Considering that the degree of myocardial damage during an AMI directly correlates to a poorer prognosis for the development of HF, reperfusion injury is a phenomenon that must be addressed for patients to have better outcomes. An inflammatory response to the myocardium is one of the components that promote myocardial damage during Ischemia/Reperfusion (I/R). Interleukin-18 is a pro-inflammatory cytokine that is elevated in the setting of acute myocardial infarction and promotes recruitment and activation of leukocytes, further upregulating the inflammatory response. Considering literature showing T-lymphocytes are involved and augmented in I/R, we hypothesize that IL-18 mediated activation of T-lymphocytes polarizes them to induce myocardial damage. By utilizing the IL-18KO mouse model, we were able to show in this study that the absence of endogenous IL-18 significantly reduced infarct size. Characterization of the differences in infiltrating leukocyte populations into the myocardium 24 hours after I/R between WT and IL-18KO showed that while IL-18KO mice display a similar percentage of infiltrating leukocytes as WT mice, they have significantly reduced populations of T-lymphocytes. IL-18KO mice had a smaller percentage of infiltrating CD4+, especially Th1 cells, and CD8+ T-cells following I/R. Further, conducting an adoptive transfer study utilizing the IL-18R KO mouse model, we were able to show that restoration of the IL-18 signaling pathway in leukocytes increased infarct size. The finding of this pilot experiment suggests that IL-18 signaling in leukocytes is a central process during inflammation that contributes to myocardial damage and increased infarct size. The results from this study pave the future direction of specifying which leukocyte populations contribute to reperfusion injury in an IL-18 dependent mechanism.

Degree

thesis:*
Name thesis:degree_name
Master of Science
Level thesis:degree_level
Thesis
Discipline thesis:degree_discipline
Physiology and Biophysics

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Dhakal, Yogesh
  • <p>https://orcid.org/0000-0002-8172-4777</p>
Contributors dc:contributor
  • Stefano Toldo
  • Fadi Salloum
  • Roland Pittman

Subjects

dc:subject × 9

Rights

dc:rights
Statement dc:rights
  • © The Author

Identifiers

dc:identifier.*

Chain of custody

source
Harvested from
Virginia Commonwealth University
Base URL
scholarscompass.vcu.edu/do/oai/
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
citation

Dhakal, Yogesh; <p>https://orcid.org/0000-0002-8172-4777</p>. The Role of Interleukin-18 in Myocardial Ischemia/Reperfusion. Thesis thesis, https://doi.org/10.25772/V9AG-JY11